The Antiasthma Medication Ciclesonide Suppresses Breast Cancer Stem Cells through Inhibition of the Glucocorticoid Receptor Signaling-Dependent YAP Pathway

Ciclesonide is an FDA-approved glucocorticoid used to treat asthma and allergic rhinitis. However, whether it has anticancer and anti-cancer stem cell (CSC) effects is unknown. This study focused on investigating the effect of ciclesonide on breast cancer and CSCs and determining its underlying mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Su-Lim, Choi, Hack Sun, Kim, Ji-Hyang, Lee, Dong-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766992/
https://www.ncbi.nlm.nih.gov/pubmed/33352739
http://dx.doi.org/10.3390/molecules25246028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766992/
https://www.ncbi.nlm.nih.gov/pubmed/33352739
http://dx.doi.org/10.3390/molecules25246028

Ejemplares similares